Receptor performance was assessed based on on ... the study opted for a modular approach, modeling ECD–ligand complexes ...

Teacher Retirement System of Texas boosted its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by ...

An imbalance in ligands, which are molecules produced by the body and the gut microbiota, can affect a key receptor protein ...

Get Instant Summarized Text (Gist) Researchers have discovered that heat causes the TRPV1 receptor, a protein involved in detecting temperature and pain, to partially unfold, leading to its activation ...

Adding nivolumab to neoadjuvant chemotherapy significantly improves response rates in high-risk early-stage ER+/HER2− breast ...

(RTTNews) - Biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND), while reporting a loss in its fourth quarter, compared to prior year's profit, on Thursday confirmed fiscal 2025 forecast.